about
Role for protease activity in visceral pain in irritable bowel syndromeRosacea: The cytokine and chemokine networkTNFα induces co-trafficking of TRPV1/TRPA1 in VAMP1-containing vesicles to the plasmalemma via Munc18-1/syntaxin1/SNAP-25 mediated fusion.Topical Ivermectin 10 mg/g and Oral Doxycycline 40 mg Modified-Release: Current Evidence on the Complementary Use of Anti-Inflammatory Rosacea TreatmentsThe neurobiology of itchPost-endocytic sorting of calcitonin receptor-like receptor and receptor activity-modifying protein 1IL-31: a new link between T cells and pruritus in atopic skin inflammationEndothelin-converting enzyme-1 regulates trafficking and signalling of the neurokinin 1 receptor in endosomes of myenteric neuronesProtease-activated receptor-4: a novel mechanism of inflammatory pain modulationTransient receptor potential ankyrin 1 mediates chronic pancreatitis pain in mice.Neural peptidase endothelin-converting enzyme 1 regulates endothelin 1-induced pruritusB cells regulate macrophage phenotype and response to chemotherapy in squamous carcinomas.Pruritus and renal failure.Pituitary adenylate cyclase activating polypeptide: an important vascular regulator in human skin in vivo.α-1-Antitrypsin and IFN-γ reduce the severity of IC-mediated vasculitis by regulation of leukocyte recruitment in vivo.Development of testicular inflammation in the rat involves activation of proteinase-activated receptor-2.Neuronal control of skin function: the skin as a neuroimmunoendocrine organ.Pathophysiology of pruritus in atopic dermatitis: an overview.New insights into rosacea pathophysiology: a review of recent findings.PAR2 absence completely rescues inflammation and ichthyosis caused by altered CAP1/Prss8 expression in mouse skin.Proteinase-activated receptors: novel signals for peripheral nerves.Protein phosphatase 2A mediates resensitization of the neurokinin 1 receptor.Neurophysiology of pruritus: interaction of itch and pain.Modern aspects of cutaneous neurogenic inflammation.Distribution and expression of non-neuronal transient receptor potential (TRPV) ion channels in rosaceaProteinase-activated receptors: transducers of proteinase-mediated signaling in inflammation and immune response.Mouse model of touch-evoked itch (alloknesis)Tumor immune escape by the loss of homeostatic chemokine expression.Pathway management in ambulatory wound care: defining local standards for quality improvement and interprofessional care.Intradermal endothelin-1 excites bombesin-responsive superficial dorsal horn neurons in the mouse.Involvement of TRPV4 in Serotonin-Evoked Scratching.The TGR5 receptor mediates bile acid-induced itch and analgesiaNeurogenic rosacea: a distinct clinical subtype requiring a modified approach to treatment.Anatomy and neurophysiology of pruritus.Pruritus in elderly patients--eruptions of senescence.Protease-activated receptors: novel PARtners in innate immunity.Clinical, cellular, and molecular aspects in the pathophysiology of rosacea.Disseminated erosive pustular dermatosis also involving the mucosa: successful treatment with oral dapsone.Psychoneuroimmunology of psychological stress and atopic dermatitis: pathophysiologic and therapeutic updates.Once-daily topical brimonidine tartrate gel 0·5% is a novel treatment for moderate to severe facial erythema of rosacea: results of two multicentre, randomized and vehicle-controlled studies.
P50
Q22241892-FB560A8A-B45B-4DB0-B15D-158D43C596D7Q27023344-D87C85FC-D720-4679-BDF4-0B2D3BF9420DQ27348801-BE8C2900-5BDA-4E32-AA3A-BD79C218F02EQ28072685-323746D2-021E-4A83-9D26-D2CCBC07256DQ28247676-011425B4-31E6-43D7-8702-4254CEF640D8Q28289037-DC046CAB-AE8C-47D2-BFCA-ACE9C676DED7Q28295839-3983BE25-9CC6-4845-B083-2129F09AB695Q28579599-E2F22BCD-35AB-4E71-981A-B9B5C71E5C10Q28580202-FF1B4776-3A45-4FE5-B5C7-DE880D2A6DFCQ30437425-E50D9338-CD94-4803-A730-7B735532D5C9Q30579223-20CAE486-1390-4258-B9EA-0E2261157CD7Q33776937-0C4AEE1D-B6FD-422C-96A1-D3EFF52C87E2Q34201430-20CCD0BA-3804-45E2-901A-1532B8519B44Q34254582-8E9E984A-1AB7-4031-9368-6DB42A182B79Q34264012-99EC1383-0E9C-4E73-996A-14A91CBB93AAQ34490290-EDEC9CDE-82BA-4ADA-82C1-ED0F61D376DDQ34570825-870595A9-4EE3-4845-947D-2F22C11CC8D6Q34600691-036670C0-7C14-4916-82E8-1D1D78DA04C4Q34657462-D921814A-74FB-4745-A470-71820723025BQ35017558-5B0FF324-6AF1-4C22-9712-05CE20FB9B07Q35209223-D66464CD-2F5B-4903-A0D9-8EE4D0AEB85DQ35322050-8EE0C0AA-FA19-4687-9153-7F6E65530B65Q35586901-C226FFAA-D9CB-44F3-B177-E264C215AD97Q35586907-80BB2EF1-C409-4300-8AAB-8168A4C4E23FQ35834762-AA95C8F7-7154-43F7-B8DB-1AE4DC6F7ECDQ36028984-C9E7D756-4F47-4957-9AFD-AA696735C499Q36032609-00F40A31-5A8D-40BA-8270-982337C641C2Q36277205-1DDA1415-A88F-4218-9A9C-79E9296C4143Q36488271-1CF71862-D82A-4613-AAF9-6ADCC93964D3Q36497290-CD666656-2095-49C9-A74C-A2313E8E7ED1Q36514748-E1DAD42D-E3B7-4C52-9B26-156D14187E77Q36733406-9BAE3E4D-861A-4C9F-B209-5FF6AAFEA43AQ36954382-F58A4E24-21C3-4043-9913-B2FF11DD830CQ36960447-4A19C55E-9D0C-4E9D-9A1D-AA45F37C818AQ36960483-7C50506E-29C8-4E30-B6F5-0931550F167EQ36989144-B0FF036A-0679-4640-B89C-E88F54C86025Q36991412-57556B76-C884-438B-AF41-6C90CE87CE07Q36991432-2CEA8CC7-0E9F-468C-BDBD-B820B1A2EFD9Q36991454-BDA477ED-12B3-4834-B3C0-5839F68788F4Q37013298-FBCAF2AD-88E3-46FD-A7E5-4EE94B3FC208
P50
description
researcher
@en
wetenschapper
@nl
name
Martin Steinhoff
@en
Steinhoff M
@nl
type
label
Martin Steinhoff
@en
Steinhoff M
@nl
altLabel
Steinhoff M
@en
prefLabel
Martin Steinhoff
@en
Steinhoff M
@nl
P106
P31
P496
0000-0002-7090-2187